These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma. Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B; Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of non-Hodgkin's lymphoma in the aged]. Mori M; Kurata K; Ikebuchi K; Fukayama M; Miwa A; Murai Y; Shimada H Rinsho Ketsueki; 1985 Sep; 26(9):1458-62. PubMed ID: 3878893 [No Abstract] [Full Text] [Related]
15. [Treatment of malignant lymphoma]. Shimoyama M Gan No Rinsho; 1989 Jan; Spec No():593-604. PubMed ID: 2783748 [No Abstract] [Full Text] [Related]
16. A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma. Shimoni A; Avivi I; Rowe JM; Yeshurun M; Levi I; Or R; Patachenko P; Avigdor A; Zwas T; Nagler A Cancer; 2012 Oct; 118(19):4706-14. PubMed ID: 22252613 [TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma]. Hosomi Y; Shibuya M Gan To Kagaku Ryoho; 2001 Oct; 28(10):1352-6. PubMed ID: 11681241 [TBL] [Abstract][Full Text] [Related]